Integrated Advisors Network’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-6,771
Closed -$268K – 676
2021
Q4
$268K Sell
6,771
-240
-3% -$10.9K 0.02% 550
2021
Q3
$351K Hold
7,011
– – 0.02% 478
2021
Q2
$389K Buy
7,011
+1,067
+18% +$56.8K 0.03% 406
2021
Q1
$278K Buy
+5,944
New +$288K 0.03% 449

Other funds holding HCAT

Integrated Advisors Network's HCAT Position: Q1 2022 in Review

Integrated Advisors Network sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 6,771 shares — an estimated $268K sold.

Integrated Advisors Network first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $389K in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Integrated Advisors Network reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Integrated Advisors Network sold 6,771 Health Catalyst shares in Q1 2022, an estimated $268K.
  • Integrated Advisors Network first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • Integrated Advisors Network's Health Catalyst position peaked at $389K in Q2 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Integrated Advisors Network's 13F filing for Q1 2022, filed 2 May 2022.